TAP employee indictments
Executive Summary
TAP Pharmaceuticals has placed four employees on administrative leave following indictments by Boston U.S. Attorney's Office July 16; two former employees were also indicted. The additional changes have no impact on TAP itself; the company previously agreed to an $875 mil. fine to settle charges related to its pricing and marketing practices. The Boston U.S. Attorney's Office has subpoenaed Express Scripts, Caremark and WellPoint for information regarding Lupron and Prevacid (1"The Pink Sheet" May 6, p. 14)...